| 000 | 00782 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250518014552.0 | ||
| 264 | 0 | _c20190403 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a2312-8852 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLangabeer, S E | |
| 245 | 0 | 0 |
_aThe JAK2 V617F mutation in lung cancer: caveat emptor. _h[electronic resource] |
| 260 |
_bExperimental oncology _cDec 2018 |
||
| 300 |
_a343-344 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xgenetics |
| 650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMyeloproliferative Disorders _xgenetics |
| 773 | 0 |
_tExperimental oncology _gvol. 40 _gno. 4 _gp. 343-344 |
|
| 999 |
_c29205860 _d29205860 |
||